Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients. | Oncologist;17(2): 233-8, 2012. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients.

Cheng, Yee Chung; Takagi, Mariko; Milbourne, Andrea; Champlin, Richard E; Ueno, Naoto T.

Affiliation

Cheng YC; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Oncologist ; 17(2): 233-8, 2012.

Article in En | MEDLINE | ID: mdl-22282904

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovary / Leuprolide / Primary Ovarian Insufficiency / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2012 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovary / Leuprolide / Primary Ovarian Insufficiency / Hematopoietic Stem Cell Transplantation Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2012 Document type: Article Affiliation country: Country of publication: